NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/25/2025
Back to search
Official data from USPTO
LIAISON NES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIAISON NES
ST13
US500000079383235Class
1, 5, 9, 10
Filing
79383235
Registration
7525844
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
07/28/2023
Registration date
10/08/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/08/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IT
Examiner
GREEN, ASHLEY ELIZABETH
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
DIASORIN S.P.A.
Representatives
Ben Natter HAUG PARTNERS, LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in science; Chemical diagnostic reagents for scientific purposes; Diagnostic preparationsother than for medical or veterinary purposes; Reagent bearing diagnostic strips for testing of infectious diseases and organic moleculesother than for medical or veterinary use; Diagnostic testing materialsother than for medical use in the nature of reagent bearing diagnostic strips for testing saliva; Control preparationschemical control solutions for in vitro diagnostic testingscreeningconfirmation and analysis for laboratory or research use; Diagnostic reagents and chemical reagents for scientific or research purposes; Solutions in the nature of chemical control solutions used in diagnostic test kits for laboratory or research purposes; Chemically treated non-medical test strips for laboratory or research purposes; Diagnostic preparations for laboratory or research use; Diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; Diagnostic biomarkers for analyticalresearch and scientific use; Diagnostic preparations for in vitro testing for scientific use; nucleic acids; nucleic acids for scientific purposes
Class 5
Medical diagnostic test reagents for testing body fluids for veterinary use; Medical diagnostic test reagents for testing body fluids for medical purposes; Diagnostic agents for medical use; Chemical reagents for medical or veterinary purposes; Diagnostic kits comprising medical diagnostic bioagents for extractingtesting and analyzing body fluids; Diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids for use in disease detectioninfectious diseasedetection of biological parameters; Diagnostic testing materials for medical usemedical diagnostic test strips for use in the field of infectious diseases and detection of biological parameters; Medical diagnostic test strips for blood analysis; Virus testing preparations for medical use; Medical diagnostic assays for medical use; In vitro medical diagnostic tests for use in disease testing; In vitro medical diagnostic assays for use in disease testing; In vitro medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing; In vitro medical diagnostic test strips for blood analysis; In vitro medical diagnostic reagents; Medical diagnostic test strips for the detectiondiagnosisscreening and confirmation of viruses and infections; Reagents and test strips for medical purposes for use as indicators of disease and such indicators being antigens and antibodies; Immunoassay reagents for medical use; Biological and chemical preparations and reagents for medical or veterinary purposes for the detection of infectious diseases; Biochemical preparations for medical or veterinary purposes for the detection of infectious diseases; Bacterial preparations for medical and veterinary use; Nucleic acid sequences for medical and veterinary purposes; Medical diagnostic regents for the detection of pathogens responsible for respiratory infections in the nature of influenzaCOVID-19 and Group A streptococcus; Medical diagnostic reagents for the detection of pathogens responsible for sexually transmitted infections
Class 9
Downloadable computer software mobile applications for use in diagnosing individuals; Downloadable computer software for medical diagnostics and for operating diagnostic apparatus that is not for medical purposes; Testing machines and instruments for diagnostic purposesother than for medical usenamely apparatuses composed of PC tablets and optical readers for testing liquids and solids; Downloadable portable and cloud-connected point of care (POC) immunodiagnostic software platforms for diagnosing individuals; Downloadable computer software and hardware for the designcreation and control of tools for medical diagnostics; Downloadable software for processing data; Apparatusequipmenthardware and computers for diagnostics; Data storageprocessing and transmission apparatus for diagnostic purposesblank tapes for storing computer data; Data processing equipmentoptical readers for diagnostic purposes; PC tablets used for test and diagnostic purposes; Video monitors; Testing apparatus not for medical purposesapparatus for testing liquids and solids; Measuring or testing machines and instruments for diagnostic purposeother than for medical useapparatus composed of PC tablets and optical readers for testing liquids and solids; Research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids
Class 10
Diagnostic testing apparatus for medical purposes for testing biomarkers and biomolecules; Medical diagnostic apparatus for medical purposes; Tools for medical diagnosticsmedical diagnostic apparatus for testing for viruses and infectious disease; Medical devices for diagnosing viruses; Medical testing equipmentmedical device for detecting antibodies against SARS-CoV-2; Medical apparatus for medical analysis of bacteria; Electronic analyzers for bacterial identification for medical purposes; Apparatus for taking blood samples; Apparatus for taking body fluid samples; Point of care (POC) diagnosticexamination and monitoring equipmentrespiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying out diagnostic tests for medical purposes; Diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2 in capillary blood samples; Diagnostic apparatus for the identification of virusbacterial infections and infectious diseases; Radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; Medical diagnostic apparatus for testing for viruses; Apparatus for DNA and RNA testing for medical purposes; Syringes for injections; Extraction medical syringes; Disposable hypodermic syringes for medical use; Medical syringe needles; Medical diagnostic apparatus for the identification of respiratory infections in the nature of influenzaSARS-CoV-2 and Group A streptococcus; Medical diagnostic apparatus for the identification of sexually transmitted infections; Molecular platform designed for the detection of pathogens causing infectious diseases through PCR nucleic acid amplification technology
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/15/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/19/2025
FIMP
FINAL DISPOSITION PROCESSED
03/19/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2024
PUBO
PUBLISHED FOR OPPOSITION
07/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2024
RFNT
REFUSAL PROCESSED BY IB
04/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/09/2024
RFRR
REFUSAL PROCESSED BY MPU
04/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/14/2024
CNRT
NON-FINAL ACTION WRITTEN
03/13/2024
DOCK
ASSIGNED TO EXAMINER
03/13/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/16/2023
Continuous trademark protection
Get notified about every new filing that threatens LIAISON NES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.